Pre-made Muromonab-Cd3 benchmark antibody (Whole mAb, anti-CD3E therapeutic antibody, Anti-CD3epsilon/IMD18/T3E/TCRE Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-921

Anti-CD3E therapeutic antibody (Pre-made Muromonab-Cd3 biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Muromonab-CD3 (trade name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants.[1][2] It is a monoclonal antibody targeted at the CD3 receptor,[3] a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.[2]

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-921-1mg 1mg 3090
GMP-Bios-INN-921-10mg 10mg Inquiry
GMP-Bios-INN-921-100mg 100mg Inquiry
GMP-Bios-INN-921-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Pre-Made Muromonab-Cd3 3Iosimilar, Whole Mab, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody
INN Name Muromonab-Cd3
FormatWhole mAb
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeIgG2a - kappa
VD LCIgG2a - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesCentocor Ortho Biotech Products LP (Raritan NJ USA) / Janssen Biotech, Inc (Horsham PA USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0